http://www.zibb.com/all/theme/cq/Watson+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 18 Nov 2009 09:52:07 GMTWed, 18 Nov 2009 09:52:07 GMT608831http://www.zibb.com/all/theme/cq/Watson+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5678286/Watson+Pharmaceuticals+names+new+senior+vice+president+of+global+operationsWatson Pharmaceuticals, a specialty pharmaceutical company, has appointed Robert Stewart as its new senior vice president of global operations. In this position, Mr Stewart will have responsibility for global manufacturing, supply chain, quality and technical operations. The company also announcedhttp://www.zibb.com/article/5678286/Watson+Pharmaceuticals+names+new+senior+vice+president+of+global+operationsWatson Pharmaceuticals IncorporatedWed, 18 Nov 2009 09:52:07 GMThttp://www.prnewswire.com/news-releases/watson-announces-presentation-time-change-at-credit-suisse-healthcare-conference-69718977.htmlWatson Announces Presentation Time Change at Credit Suisse Healthcare Conference.http://www.prnewswire.com/news-releases/watson-announces-presentation-time-change-at-credit-suisse-healthcare-conference-69718977.htmlWatson Pharmaceuticals IncorporatedWed, 11 Nov 2009 02:12:00 GMThttp://www.foxbusiness.com/story/markets/industries/health-care/watson-pharmaceuticals-posts-lower-profit/Watson Pharmaceuticals Posts Lower Profithttp://www.foxbusiness.com/story/markets/industries/health-care/watson-pharmaceuticals-posts-lower-profit/Watson Pharmaceuticals IncorporatedWed, 04 Nov 2009 12:47:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-21-2009/0005097338&EDATE=MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson has joined the Company as Executive Vice President, Global Brands. In this newly expanded position Mr.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-21-2009/0005097338&EDATE=Watson Pharmaceuticals IncorporatedMon, 21 Sep 2009 12:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=156548&full=1MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals , a leader in generic and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson has joined the Company as Executive Vice President, Global Brands. In this newly expanded position Mr.http://www.biospace.com/news_story.aspx?StoryID=156548&full=1Watson Pharmaceuticals IncorporatedMon, 21 Sep 2009 00:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7613News and press releases from the pharmaceutical industry. Comprehensive news coverage for the pharmaceutical sector from PharmiWeb.comhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7613Watson Pharmaceuticals IncorporatedThu, 20 Aug 2009 01:00:00 GMThttp://www.pharmaasia.com/article-7880-watsonpharmaceuticalsandarrowgroupreceiveftcsecondrequest-asia.htmlWatson Pharmaceuticals has received a request for additional information from the Federal Trade Commission (FTC) in connection with the company’s pending acquisition of privately held Arrow Group.http://www.pharmaasia.com/article-7880-watsonpharmaceuticalsandarrowgroupreceiveftcsecondrequest-asia.htmlWatson Pharmaceuticals IncorporatedThu, 13 Aug 2009 00:00:00 GMThttp://www.drugstorenews.com/story.aspx?id=112571Watson Pharmaceuticals announced Monday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the United States is being voluntarily recalled from wholesalers and pharmacies.http://www.drugstorenews.com/story.aspx?id=112571Watson Pharmaceuticals IncorporatedMon, 10 Aug 2009 12:45:00 GMThttp://www.pharmalive.com/News/index.cfm?articleid=641779&categoryid=24PharmaLive: Watson Pharmaceuticals, Inc. (NYSE:WPI) , a leader in generic and specialty branded pharmaceuticals, today announced a license agreement with GeneraMedix, Inc., for the exclusive US marketing rights to a generic version of Ferrlecit (sodium ferric gluconate complex in sucrosehttp://www.pharmalive.com/News/index.cfm?articleid=641779&categoryid=24Watson Pharmaceuticals IncorporatedThu, 30 Jul 2009 02:10:31 GMThttp://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/07/27/financial/f142131D04.DTL&feed=rss.businessWatson Pharmaceuticals Inc. said Monday Chief Financial Officer Mark W. Durand has taken a leave of absence due to health reasons. R. Todd Joyce, vice president, controller and treasurer, has been appointed acting principal financial officer, the company... <ahttp://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/07/27/financial/f142131D04.DTL&feed=rss.businessWatson Pharmaceuticals IncorporatedMon, 27 Jul 2009 21:22:30 GMThttp://www.newsvine.com/_news/2009/07/27/3077702-watson-pharmaceuticals-cfo-takes-leaveWatson Pharmaceuticals Inc. said Monday Chief Financial Officer Mark W. Durand has taken a leave of absence due to health reasons.http://www.newsvine.com/_news/2009/07/27/3077702-watson-pharmaceuticals-cfo-takes-leaveWatson Pharmaceuticals IncorporatedMon, 27 Jul 2009 21:21:31 GMThttp://www.bomgar.com/blog/events/conferences/video-helpdesk-institute-2009-vegasVIDEO: Bomgar customers speak out at the Help Desk Institute Annual Conference and Expo in Vegas, 2009 – Enterprise Remote Support Software Blog | BOMGARhttp://www.bomgar.com/blog/events/conferences/video-helpdesk-institute-2009-vegasWatson Pharmaceuticals IncorporatedThu, 14 May 2009 15:52:19 GMThttp://www.news-medical.net/?id=48742Watson Pharmaceuticals, Inc. has confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration seeking approval to market its guaifenesin extended-release 600mg and 1200mg tablets and its dextromethorphan HBr/guaifenesin extended-releasehttp://www.news-medical.net/?id=48742Watson Pharmaceuticals IncorporatedThu, 23 Apr 2009 04:10:00 GMThttp://seekingalpha.com/article/113302-ebay-stock-fully-valued-at-current-price?source=yahooI thought that eBay (EBAY) may be a good play on frugality in 2009. The stock is off 53% this year. It is trading at historically low PE and similar relative value metrics, has lots of cash and no long term debt.http://seekingalpha.com/article/113302-ebay-stock-fully-valued-at-current-price?source=yahooWatson Pharmaceuticals IncorporatedTue, 06 Jan 2009 15:08:58 GMThttp://news.yahoo.com/s/ap/20081231/ap_on_bi_st_ma_re/wall_street_stocksStocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and Nasdaq Stock Market: News, Headlines and Latest Stories on Yahoo! Newshttp://news.yahoo.com/s/ap/20081231/ap_on_bi_st_ma_re/wall_street_stocksWatson Pharmaceuticals IncorporatedWed, 31 Dec 2008 23:39:51 GMThttp://biz.yahoo.com/ap/081231/wall_street_stocks.html?.v=2General Motors, Eli Lilly are big movers. - NEW YORK (AP) -- Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and Nasdaq Stock Market:http://biz.yahoo.com/ap/081231/wall_street_stocks.html?.v=2Watson Pharmaceuticals IncorporatedWed, 31 Dec 2008 23:39:51 GMThttp://www.redorbit.com/news/health/1616286/c_o_r_r_e_c_t_i_o_n/index.html?source=r_healthIn the news release, Watson Pharmaceuticals, Inc. (NYSE: WPI) Receives FDA Final Approval for Generic Mircette(R), issued earlier today by Watson Pharmaceuticals, Inc.http://www.redorbit.com/news/health/1616286/c_o_r_r_e_c_t_i_o_n/index.html?source=r_healthWatson Pharmaceuticals IncorporatedTue, 30 Dec 2008 00:49:00 GMThttp://www.pharmaceutical-business-review.com/article_news.asp?guid=30E02348-922A-4FB7-9CB8-FC63131C7471Cephalon and its wholly-owned subsidiary Cima Labs have filed a lawsuit in the US District Court in Delaware against Watson Pharmaceuticals and its wholly owned subsidiary, Watson Laboratories for infringement of US patent, which cover methods of use for the Cephalon product Fentora.http://www.pharmaceutical-business-review.com/article_news.asp?guid=30E02348-922A-4FB7-9CB8-FC63131C7471Watson Pharmaceuticals IncorporatedWed, 04 Jun 2008 15:06:00 GMThttp://www.newratings.com/en/main/company_headline.m?id=1752462NEW YORK, May 28 (newratings.com) - Analyst M Goodman of Credit Suisse maintains his "neutral" rating on Watson Pharmaceuticals Inc (ticker: WPI). The target price is set to $33. [more]http://www.newratings.com/en/main/company_headline.m?id=1752462Watson Pharmaceuticals IncorporatedWed, 28 May 2008 11:13:33 GMThttp://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D8V7DRGG0NEW YORK (AP) - Shares of Big Lots Inc. rose Wednesday, helping send the Standard & Poor's 500 Index higher in midday trading, after the discount retailer's fourth-quarter profit declined but still beat Wall Street expectations. Big Lots rose $3.82, or 22 percent, to $21.19.http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D8V7DRGG0Watson Pharmaceuticals IncorporatedWed, 05 Mar 2008 17:49:00 GMThttp://www.manufacturing.net/article.aspx?id=154904Facility has been subject to a new product hold by the FDA since 2005; regulators won't approve any new drugs that would be produced at the site until manufacturing problems there are fixed.http://www.manufacturing.net/article.aspx?id=154904Watson Pharmaceuticals IncorporatedThu, 14 Feb 2008 09:14:00 GMThttp://www.bloomberg.com/apps/news?pid=20601103&sid=aEF8qBDI0L1g&refer=usFeb. 12 (Bloomberg) -- Johnson & Johnson and Novartis AG's Sandoz unit recalled some patches containing the painkiller fentanyl, saying manufacturing defects may cause leaks that can lead to fatal overdoses. The Duragesic patches, made by Johnson & Johnson's Alza Corp.http://www.bloomberg.com/apps/news?pid=20601103&sid=aEF8qBDI0L1g&refer=usWatson Pharmaceuticals IncorporatedTue, 12 Feb 2008 23:38:07 GMThttp://www.thestreet.com/_yahoo/newsanalysis/drugs/10392807.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NABiovail, which filed suit to protect Cardizem, has granted Watson licensing rights to the drug.. Check out TheStreet for the latest stock market news and financial investment headlines.http://www.thestreet.com/_yahoo/newsanalysis/drugs/10392807.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NAWatson Pharmaceuticals IncorporatedTue, 04 Dec 2007 16:45:35 GMThttp://www.fda.gov/cder/pediatric/exgrant.htmThis list simply identifies approved active moieties with sponsors to which FDA has granted exclusivity for pediatric studies. Only applications held by the identified sponsor were granted pediatric exclusivity.http://www.fda.gov/cder/pediatric/exgrant.htmWatson Pharmaceuticals IncorporatedThu, 25 Oct 2007 13:25:00 GMThttp://www.pharmpro.com/ShowPR~PUBCODE~021~ACCT~0000100~ISSUE~0812~RELTYPE~PR~ORIGRELTYPE~IN~PRODCODE~0000~PRODLETT~GK.htmlWatson Pharmaceuticals, Inc. has announced that its subsidiary, Watson Laboratories, Inc., has received final approval today from the FDA on its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets (XL) in the 150 mg strength. Bupropion Hydrochloridehttp://www.pharmpro.com/ShowPR~PUBCODE~021~ACCT~0000100~ISSUE~0812~RELTYPE~PR~ORIGRELTYPE~IN~PRODCODE~0000~PRODLETT~GK.htmlWatson Pharmaceuticals Incorporated